Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
October 18, 2017
AbbVie

AbbVie to Present at the 2017 Credit Suisse Health Care Conference

AbbVie will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017

AbbVie to Present at the 2017 Credit Suisse Health Care Conference

AbbVie will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017

-
AbbVie
-
October 18, 2017

NORTH CHICAGO, Ill., Oct. 18, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017. Bill Chase, executive vice president and chief financial officer, will present at 12 p.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.    

About AbbVie AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.  In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.

SOURCE AbbVie

Contact(s)

AbbVie
Media
Adelle Infante
adelle.infante@abbvie.com
(847) 938-8745

AbbVie
Investors
Liz Shea
liz.shea@abbvie.com
(847) 935-2211

Last updated:
October 18, 2017

AbbVie

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

NORTH CHICAGO, Ill., Oct. 18, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017. Bill Chase, executive vice president and chief financial officer, will present at 12 p.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.    

About AbbVie AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.  In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.

SOURCE AbbVie

Contact(s)

AbbVie
Media
Adelle Infante
adelle.infante@abbvie.com
(847) 938-8745

AbbVie
Investors
Liz Shea
liz.shea@abbvie.com
(847) 935-2211

Last updated:
October 18, 2017

AbbVie

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail